ArticleBMJ open diabetes research & care2020

PERsistent Sitagliptin treatment & Outcomes (PERS&O 2.0) study, long-term results: a real-world observation on DPP4-inhibitor effectiveness.

Antonio Carlo Bossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.